{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=11", "query": { "condition": "Vascular", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 15039, "total_pages": 1504, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T04:18:32.281Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03824366", "title": "Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Malignancy", "Metastasis", "Hemoptysis", "Gastrointestinal Bleeding", "Pelvic Bleeding", "Superior Vena Cava Syndrome", "Mediastinal Disease" ], "interventions": [ { "name": "Volumetric MR imaging", "type": "DEVICE" }, { "name": "Radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DEVICE", "RADIATION" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2019-04-23", "completion_date": "2022-01-14", "has_results": true, "last_update_posted_date": "2025-01-10", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03824366" }, { "nct_id": "NCT05050266", "title": "Enhancing Mental and Physical Health of Women Veterans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Diseases", "Overweight", "Obesity", "Smoking", "Hypertension", "Cholesterol", "Diabetes Mellitus", "Prediabetic State", "Pregnancy", "Depression, Postpartum", "Prevention", "Implementation Science", "Quality Improvement", "Virtual Care" ], "interventions": [ { "name": "EBQI", "type": "BEHAVIORAL" }, { "name": "REP", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 20, "start_date": "2021-10-21", "completion_date": "2026-10-30", "has_results": false, "last_update_posted_date": "2026-11-10", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "West Los Angeles, California", "locations": [ { "city": "West Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05050266" }, { "nct_id": "NCT01409031", "title": "Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Persistent Pulmonary Hypertension", "Respiratory Failure" ], "interventions": [ { "name": "Intravenous Sildenafil", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "72 Hours", "sex": "ALL", "summary": "Up to 72 Hours" }, "enrollment_count": 3, "start_date": "2011-07", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2019-02-01", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 7, "location_summary": "Aurora, Colorado • Chicago, Illinois • Buffalo, New York + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Buffalo", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01409031" }, { "nct_id": "NCT03485820", "title": "A Novel Transition Program to Reduce Disability After Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ischemic Stroke", "Hemorrhagic Stroke" ], "interventions": [ { "name": "COMPASS", "type": "BEHAVIORAL" }, { "name": "Stroke education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 185, "start_date": "2018-01-09", "completion_date": "2024-02-28", "has_results": true, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03485820" }, { "nct_id": "NCT06835959", "title": "Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension in Pregnancy", "Chronic Hypertension", "Gestational Hypertension" ], "interventions": [ { "name": "Moms@Home", "type": "BEHAVIORAL" }, { "name": "Enhanced Standard of Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 100, "start_date": "2025-05-16", "completion_date": "2027-11-16", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06835959" }, { "nct_id": "NCT00260923", "title": "A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "aliskiren", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 641, "start_date": "2005-11", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2011-11-08", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00260923" }, { "nct_id": "NCT06402123", "title": "A Phase 2b Study of Zagociguat in Patients With MELAS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)" ], "interventions": [ { "name": "zagociguat 15mg", "type": "DRUG" }, { "name": "zagociguat 30mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tisento Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 43, "start_date": "2024-09-10", "completion_date": "2026-06-29", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 10, "location_summary": "La Jolla, California • Aurora, Colorado • Atlanta, Georgia + 5 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06402123" }, { "nct_id": "NCT02820480", "title": "Design of an Affordable Gym for Post Stroke Rehabilitation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke", "Cerebral Palsy", "Healthy" ], "interventions": [ { "name": "Rehab in a Crate System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2015-11", "completion_date": "2019-08", "has_results": false, "last_update_posted_date": "2019-10-14", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02820480" }, { "nct_id": "NCT00002262", "title": "A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sarcoma, Kaposi", "HIV Infections" ], "interventions": [ { "name": "Tumor Necrosis Factor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "18 Years to 70 Years · Male only" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002262" }, { "nct_id": "NCT00719888", "title": "Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Biphenotypic Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Burkitt Lymphoma", "Chronic Lymphocytic Leukemia", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Follicular Lymphoma", "Lymphoblastic Lymphoma", "Lymphoplasmacytic Lymphoma", "Mantle Cell Lymphoma", "Marginal Zone Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Non-Hodgkin Lymphoma", "Plasma Cell Myeloma", "Prolymphocytic Leukemia", "Refractory Anemia", "Small Lymphocytic Lymphoma" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Double-Unit Umbilical Cord Blood Transplantation", "type": "PROCEDURE" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Umbilical Cord Blood Transplantation", "type": "PROCEDURE" }, { "name": "Thiotepa", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER", "RADIATION" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "65 Years", "sex": "ALL", "summary": "6 Months to 65 Years" }, "enrollment_count": 135, "start_date": "2005-11-18", "completion_date": "2024-12-19", "has_results": true, "last_update_posted_date": "2025-03-07", "last_synced_at": "2026-11-15T04:18:32.281Z", "location_count": 3, "location_summary": "Aurora, Colorado • Seattle, Washington", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00719888" } ] }